Overland Park, KSNCT05826665Now EnrollingIRB Ready

Persistent Atrial Fibrillation Clinical Trial in Overland Park, KS

Access cutting-edge persistent atrial fibrillation treatment through this clinical trial at a research site in Overland Park. Study-provided care at no cost to qualified participants.

Sponsored by Kansas City Heart Rhythm Research Foundation

Quick Self-Assessment

See if you qualify for this Overland Park location

Preparing your pre-screening questions…

Expert Care in Overland Park

Access persistent atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related persistent atrial fibrillation treatment provided free

Apply for This Overland Park Location

Check if you qualify for this persistent atrial fibrillation clinical trial in Overland Park, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Overland Park

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Overland Park site if eligible
  4. 4Begin participation

About This Persistent Atrial Fibrillation Study in Overland Park

STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.

Sponsor: Kansas City Heart Rhythm Research Foundation

Who Can Participate

Inclusion Criteria

Indication for ablation of persistent AF
Age \>18 years
Persistent AF \>7 days and total continuous duration \<2 years
Patients have previously undergone pulmonary vein isolation, using any technique and have had AF recurrence.
Patients have limited additional ablation at their first procedure (e.g. right atrial flutter line).

Exclusion Criteria

Patients with previous ablation in more than one region of the left atrium in addition to the pulmonary veins.
Patients with longstanding persistent AF (continuous duration \>2 years) or significant substrate (mitral valve disease, scarring, very dilated atria \>50mm).
Creatinine clearance estimated glomerular filtration rate (eGFR) \<30mls/min
Contraindication to anticoagulation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Overland Park?

Yes, this clinical trial (NCT05826665) has an active research site in Overland Park, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Persistent Atrial Fibrillation Treatment Options in Overland Park, KS

If you're searching for persistent atrial fibrillation treatment options in Overland Park, KS, this clinical trial (NCT05826665) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Overland Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced persistent atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all persistent atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Overland Park, KS

See all atrial fibrillation clinical trials recruiting in Overland Park — not just this study.

Browse Atrial Fibrillation Trials in Overland Park

Ready to Join in Overland Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Overland Park, KS